IP Library Granted Patent US 7,108,683
Granted Patent B2
US 7,108,683 · App. 10/135,741 · Granted Sep 19, 2006

Wound therapy and tissue management system and method with fluid differentiation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,108,683
App. No.
10/135,741
Granted
Sep 19, 2006
Kind
B2
Abstract

A wound therapy and tissue management system utilizes fluid differentiation. Fluid is differentiated by establishing a gradient within the system. A gradient can be established with matter or energy. Patient interfaces for establishing, maintaining and varying one or more gradients include transfer elements with first and second zones having different flow coefficients. The transfer elements exchange fluid with a patient, generally through a wound site, and with external components of the system. Osmotic solution gradients are controlled by a methodology involving the present invention for extracting solutions, which can include toxins, from patients and for introducing fluids and sumping air to wound sites.

Claims (50)

1. A fluid-differentiating wound therapy and tissue management system, which comprises:

a) a fluid transfer element including:

1) a non-attaching patient contact surface;

2) a first zone with a first fluid transfer coefficient;

3) a second zone with a second fluid transfer coefficient different from said first fluid transfer coefficient, said second zone being located adjacent to said first zone; and

4) a predetermined fluid flow path through said element guided by said fluid transfer coefficient differential between said first and second zones;

b) a cover placed over said transfer element in contact therewith and including adhesive adapted for adhering said cover to a patient around the perimeter of said fluid transfer element;

c) a gradient source for creating a gradient across said transfer element whereby fluids are moved through said transfer element;

d) an effluent conduit connected to said transfer element and adapted for discharging effluent from the system; and

e) said predetermined fluid flow path being towards said effluent conduit.

2. The system of claim 1 with a pressure gradient source.

3. The system of claim 2 with the pressure gradient source comprising a vacuum source.

4. The system of claim 2 with a pump.

5. The system of claim 1 with an inlet conduit.

6. The system of claim 1 with a draped material cover.

7. The system of claim 1 with first and second layers of sponge material.

8. The system of claim 1 with fluid flow characteristic zones.

9. The system of claim 8 with intermingled sponge material.

10. The system of claim 1 with a temperature gradient.

11. The system of claim 1 with an oxygen concentration gradient.

12. The system of claim 1 with a fluid concentration gradient.

13. The system of claim 1 with an oncotic gradient.

14. The system according to claim 1 wherein said gradient comprises an osmotic gradient.

15. The system of claim 1 with a programmable controller.

16. The system of claim 15 wherein the controller is programmed.

17. The system of claim 1 with a multiple-passage conduit.

18. The system of claim 1 with an input to the transfer element.

19. The system of claim 1 with a monitor and a feedback loop.

20. A fluid-differentiating wound therapy and tissue management method, which includes steps of:

a) providing a fluid transfer element with a patient contact surface, a first zone with a first fluid transfer coefficient and a second zone located adjacent to said first zone with a second fluid transfer coefficient different from said first fluid transfer coefficient;

b) providing a predetermined flow path through said element guided by said liquid fluid transfer coefficient differential between said first and second zones;

c) mounting said transfer element on said patient in communication with a wound site;

d) covering said transfer element with a cover;

e) releasably adhering said cover to said patient around said wound site;

f) providing a gradient source;

g) connecting said gradient source to said transfer element;

h) establishing a gradient across said transfer element;

i) providing an effluent conduit and directing said predetermined fluid flow path towards said effluent conduit;

j) connecting said effluent conduit to said transfer element and to said gradient source;

k) differentiating the fluid within the enclosure; and

l) draining liquid from said transfer element.

21. A fluid-differentiating wound therapy and tissue management system, which comprises:

a) a fluid transfer element including:

1) a patient contact surface;

2) a first zone with a first fluid transfer coefficient;

3) a second zone with a second fluid transfer coefficient different from said first fluid transfer coefficient, said second zone being located adjacent to said first zone; and

4) a predetermined fluid flow path through said element guided by said fluid transfer coefficient differential between said first and second zones;

b) a cover placed over said transfer element in contact therewith and adapted for contact with the patient around the perimeter of said fluid transfer element;

c) a gradient source for creating an oncotic gradient across said transfer element; and

d) an effluent conduit connected to said transfer element and adapted for discharging effluent from the system.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →